Evidence map›Paper›PMID 37426824›Full record

ArticleFrontiers in pharmacology2023

Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients.

Abdelrahman Alaa, Neven Sarhan, Mohamed Gamal Lotfy El-Ansary, Naglaa Samir Bazan, Khaled Farouk, Raed Shahat Ismail, Mona Farag Schalaan, Adel R A Abd-Allah

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Abdelrahman AlaaClinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt.
Neven SarhanClinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt.
Mohamed Gamal Lotfy El-AnsaryCritical Care Medicine Department, Kasr Al Ainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt.
Naglaa Samir BazanCritical Care Medicine Department, Kasr Al Ainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt.
Khaled FaroukCritical Care Medicine Department, Kasr Al Ainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt.
Raed Shahat IsmailPharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
Mona Farag SchalaanBiochemistry Department, Faculty of pharmacy, Misr International University, Cairo, Egypt.
Adel R A Abd-AllahPharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
Cairo University · EGMisr International University · EGAl-Azhar University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE1ACE2COVID-19genetic polymorphismseverityTMPRSS2

Identifiers

PMID37426824
PMCPMC10323191
OpenAlexW4381854980

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.